A malaria vaccine is approved by the World Health Organisation

MALARIA IS ONERTS,SWHORTS,SWHORTS,SRTS,S of medical science’s most formidable foes. The search for a vaccine has been going on for decades. Dozens of candidates have been tested in recent years. But so far only one, a jab called , made by GlaxoSmithKline, has proved effective in the final stages of clinical trials. On October 6th the World Health Organisation () recommended for use in childhood vaccination in places with transmission of , the deadliest of the five parasites that cause malaria, and the most common in Africa.The reached its decision after reviewing results from Ghana, Kenya and Malawi, where more than 800,000 infants were vaccinated with a four-dose regimen. In these countries was included among the routine childhood vaccines distributed by primary health-care centres. This implementation programme, in which reduced by 30% the number of cases of severe malaria which led to hospital admissions, therefore measured what kind of efficacy can be expected if the vaccine is rolled out widely across Africa.